Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Injection Site in Total Knee Arthroplasty
NCT00632580Phase 4Unknown
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jan 2008
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Pain at 48 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00632580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632580.